LRMR earnings: a negative outcome, -8.7%

On November 12, 2021, Larimar Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -8.7% in the window around the event. It had already run +10.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.